Document:

Warrant for Issuance of Common Stock

 Exhibit 10.30 
  
 WARRANT FOR ISSUANCE OF COMMON STOCK 
 OF 
 HEALTHESSENTIALS SOLUTIONS, INC. 
  
 THE TRANSFER OF THIS WARRANT IS RESTRICTED BY THE TERMS OF THIS WARRANT. EXCEPT AS PROVIDED HEREIN, THIS WARRANT MAY NOT BE
GIVEN, SOLD, PLEDGED OR OTHERWISE TRANSFERRED. 
  

			
	 No. W-1
	  	Warrant to Purchase 95,098 Shares of Common Stock
		
	 	  	Void after May 1, 2012

  
 For value received,
HEALTHESSENTIALS SOLUTIONS, INC., a Delaware corporation (the “Company”) hereby certifies that, Jose Raffinan, M.D. and Maria Raffinan, M.D., each an individual with a primary residence in Florida, or permitted assigns (the
“Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, Ninety-five Thousand Ninety-eight (95,098) shares of common stock, without par value, of the Company (“Warrant Shares”), as constituted
on April 30, 2002 (the “Warrant Issue Date”), upon surrender hereof, at the principal office of the Company referred to below, with the Notice of Exercise attached hereto duly executed, and simultaneous payment therefor in lawful money of
the United States as hereinafter provided, at the per Warrant Share price of Zero Dollars and One Cent ($0.01) (the “Exercise Price”). The number, character and Exercise Price of such shares of Warrant Shares are subject to adjustment as
provided below. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. This Warrant is registered and its transfer may be registered upon the books
maintained for that purpose by the Company by delivery of this Warrant duly endorsed. 
  
 1. Term of Warrant. Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole or in part, during the term commencing on the Warrant Issue Date and ending at 5:00 p.m.,
Eastern Standard Time, on May 1, 2012, and shall be void thereafter. 
  
 2. Exercise of Warrant. 
  
 2.1. Method.
The purchase rights represented by this Warrant are exercisable by the Holder in whole or in part, at any time, or from time to time, during the term hereof as described in Section 1 above, by the surrender of this Warrant and the Notice of Exercise
annexed hereto duly completed and executed by the Holder, at the office of the Company (or such other office or agency of the Company as it may designate by notice in writing to the Holder), upon payment (a) in cash or by wire transfer to a bank
account designated by the Company or by a certified or cashier’s check, (b) by cancellation by the Holder of indebtedness of the Company to the Holder, or (c) by a combination of (a) and (b), of the Exercise Price of the shares to be purchased;
provided, however, that if less than all of the purchase rights represented by this Warrant are exercised, such exercise shall involve the purchase of at least Ten Thousand (10,000) shares of Warrant Shares, adjusted as provided in Section 6 below.

  

 2.2. Effect. This Warrant shall be deemed to have been exercised at the time of its surrender for
exercise as provided above, and the person entitled to receive the shares of common stock issuable upon such exercise (“Common Stock”) shall be treated for all purposes as the holder of record of such shares at and after such time. As
promptly as practicable on or after such date and in any event within ten (10) days thereafter, the Company at its expense shall issue to the person entitled to receive the same a certificate for the number of shares of Common Stock issuable upon
such exercise. If this Warrant is exercised in part, the Company at its expense will execute and deliver a new Warrant exercisable for the number of shares for which this Warrant may then be exercised. 
  
 2.3. Holder Not A Shareholder. The Holder shall neither be entitled to
vote nor receive dividends nor be deemed the holder of Common Stock or any other securities of the Company that may at any time be issuable on the exercise hereof for any purpose until the Warrant has been exercised as provided in this Section 2.

  
 2.4. No Fractional Shares or Scrip. No fractional
shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall make a cash payment equal to the Exercise Price
multiplied by such fraction. 
  
 3. Ownership Restrictions.

  
 3.1. Record Ownership. The Company shall maintain a
register of the Holders of the Warrants (the “Register”) showing their names and addresses and the serial numbers and number of Common Shares purchasable issued to or transferred of record by them from time to time. The Register may be
maintained in electronic, magnetic or other computerized form. The Company may treat the person named as the Holder of this Warrant in the Register as the sole owner of this Warrant. The Holder of this Warrant is the person exclusively entitled to
receive notifications with respect to this Warrant, exercise it to purchase shares of Common Stock and otherwise exercise all of the rights and powers as the absolute owner hereof. 
  
 3.2. Registration of Transfer. This Warrant may not be transferred by the Holder, except upon approval by the
Company; provided, however, that any requested transfers by the Holder to a trust where the beneficiary of such trust is the Holder will not be unreasonably withheld. Permitted transfers of this Warrant may be registered on the books of the Company
maintained for such purpose pursuant to Section 3.1 above (i.e., the Register). Transfers shall be registered when this Warrant is presented to the Company duly endorsed with a request to register the transfer hereof and the Company has accepted
such transfer. When this Warrant is presented for transfer and duly transferred hereunder, it shall be canceled and a new Warrant showing the name of the transferee as the Holder thereof shall be issued in lieu hereof. 
  
 3.3. Worn and Lost Warrants. If this Warrant becomes worn, defaced or
mutilated but is still substantially intact and recognizable, the Company or its agent may issue a new Warrant in lieu hereof upon its surrender. If this Warrant is lost, destroyed or wrongfully taken, the Company shall issue a new Warrant in place
of the original Warrant if the Holder so requests 

  

 - 2 - 

 
by written notice to the Company and the Holder has delivered to the Company an indemnity agreement reasonably satisfactory to the Company with an affidavit
of the Holder that this Warrant has been lost, destroyed or wrongfully taken. 
  
 3.4. Restrictions on Transfer. This Warrant and the Common Stock issuable upon the exercise hereof have not been registered under the Act or any applicable state securities laws and this Warrant and the Common
Stock issuable upon the exercise of this Warrant may not be offered for sale or sold unless such offer or sale is registered under the appropriate securities laws or such transfer is exempt from such registration and the Company has received an
opinion of counsel, reasonably satisfactory to the Company in form and substance, stating that such offer or sale is exempt from registration under applicable state and federal securities laws. In addition, the Holder may only transfer this Warrant
and the Common Stock issuable upon the exercise hereof with the prior written consent of the Company. Further, the Common Stock issuable upon exercise hereof shall be subject to the Company’s standard shareholders agreement. 
  
 3.5. Legend. Upon any exercise of a Warrant, the certificates
representing the securities purchased thereby shall bear the following legend: 
  
 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY APPLICABLE STATE SECURITIES LAWS AND THESE SECURITIES MAY NOT BE OFFERED FOR SALE OR SOLD UNLESS THEY ARE REGISTERED UNDER THE
APPROPRIATE SECURITIES LAWS OR THEY OR SUCH OFFER OR SALE ARE EXEMPT FROM SUCH REGISTRATION AND THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL TO THAT EFFECT, REASONABLY SATISFACTORY TO THE COMPANY IN FORM AND SUBSTANCE. 
  
 3.6. Warrant Agent. The Company may, by written notice to the Holder
appoint an agent for the purpose of maintaining the Register issuing Common Stock or other securities then issuable upon the exercise of this Warrant, exchanging or transferring this warrant, or any or all of the foregoing. Thereafter, any such
registration issuance, exchange, or transfer, as the case may be, shall be made at the office of such agent. 
  
 4. Reservation of Stock. The Company covenants that, during the term this Warrant is exercisable, the Company will reserve from its authorized and
unissued Common Stock a sufficient number of Shares to provide for the issuance of Common Stock upon the exercise of this Warrant and, if at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the
conversion of all then outstanding shares of the Common Stock, the Corporation will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number of
shares as shall be sufficient for such purpose, including without limitation, engaging in best efforts to obtain the requisite shareholder approval of any necessary amendment to its Certificate of Incorporation (the “Articles”). The
Company further covenants that all shares that may be issued upon the exercise of rights represented by this Warrant, upon exercise of the rights 

  

 - 3 - 

 
represented by this Warrant and payment of the Exercise Price, all as set forth herein, will be duly authorized, validly issued, fully paid, non-assessable
and free from all taxes, liens and charges in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously or otherwise specified herein). The Company agrees that its issuance of this Warrant shall constitute
full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for shares of Common Stock upon the exercise of this Warrant. 
  
 5. Distributions. If: (a) the Company sets a record date for the
holders of its Common Stock (or other stock or securities at the time receivable upon the exercise of this Warrant) for the purpose of entitling them to receive any dividend or other distribution, or any right to subscribe for or purchase any shares
of stock of any class or any other securities, or to receive any other right, or; (b) there is any capital reorganization of the Company, any reclassification of the capital stock of the Company, any consolidation or merger of the Company with or
into another entity, or any conveyance of all or substantially all of the assets of the Company or (c) there is any voluntary dissolution, liquidation or winding-up of the Company, the Company will mail to the Holder a notice specifying, as the case
may be, (A) the record date for the purpose of such dividend, distribution or right, and the amount and character of such dividend, distribution or right, or (B) the date on which such reorganization, reclassification, consolidation, merger,
conveyance, dissolution, liquidation or winding-up is to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock (or such other Stock or securities) for securities or other property deliverable upon such
reorganization, reclassification, consolidation, merger, conveyance, dissolution, liquidation or winding-up. Such notice shall be mailed at least fourteen (14) days prior to the date therein specified. 
  
 6. Adjustments. The Exercise Price and the number of shares
purchasable hereunder are subject to adjustment from time to time as follows: 
  
 6.1. Merger, Sale of Assets, etc. If, at any time while this Warrant or any portion thereof is outstanding and unexpired, there shall be (a) a reorganization (other than a combination, reclassification,
exchange or subdivision of shares otherwise provided for herein), (b) a merger or consolidation of the Company with or into another corporation in which the Company is not the surviving entity, or a reverse triangular merger in which the Company is
the surviving entity but the shares of the Company’s capital stock outstanding immediately prior to the merger are converted by virtue of the merger into other property, whether in the form of securities, cash, or otherwise, or (c) a sale or
transfer of the Company’s properties and assets as, or substantially as, an entirety to any other person, then, as a part of such reorganization, merger, consolidation, sale or transfer, lawful provision shall be made so that the holder of this
Warrant shall thereafter be entitled to receive upon exercise of this Warrant, during the period specified herein, and upon payment of the Exercise Price then in effect, the number of shares of stock or other securities or property of the successor
corporation resulting from such reorganization, merger, consolidation, sale or transfer that a holder of the shares deliverable upon exercise of this Warrant would have been entitled to receive in such reorganization, consolidation, merger, sale

  

 - 4 - 

 
or transfer if this Warrant had been exercised immediately before such reorganization, merger, consolidation, sale or transfer, all subject to further
adjustment as provided in this Section 6. The foregoing provisions of this Section 6.1 shall similarly apply to successive reorganizations, consolidations, mergers, sales and transfers and to the stock or securities of any other corporation that are
at the time receivable upon the exercise of this Warrant. If the per-share consideration payable to the Holder hereof for shares in connection with any such transaction is in a form other than cash or marketable securities, then the value of such
consideration shall be determined in good faith by the Company’s Board of Directors. In all events, appropriate adjustment (as determined in good faith by the Company’s Board of Directors) shall be made in the application of the provisions
of this Warrant with respect to the rights and interests of the Holder after the transaction, to the end that the provisions of this Warrant shall be applicable after that event, as near as reasonably may be, in relation to any shares or other
property deliverable after that event upon exercise of this Warrant. 
  
 6.2. Reclassification, etc. If the Company, at any time while this Warrant or any portion thereof remains outstanding and unexpired, by reclassification of securities or otherwise, shall change any of the securities as to which
purchase rights under this Warrant exist into the same or a different number of securities of any other class or classes, this Warrant shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as
the result of such change with respect to the securities that were subject to the purchase rights under this Warrant immediately prior to such reclassification or other change and the Base Price and Exercise Price therefor shall be appropriately
adjusted, all subject to further adjustment as provided in this Section 6. 
  
 6.3. Split, Subdivision or Combination. If the Company, at any time while this Warrant or any portion thereof remains outstanding and unexpired, shall split, subdivide or combine the securities as to which
purchase rights under this Warrant exist, into a different number of securities of the same class, the Base Price for such securities shall be proportionately decreased in the case of a split or subdivision or proportionately increased in the case
of a combination, and the number of shares of Common Stock for which this Warrant is exercisable shall be proportionately increased in the case of a split or subdivision or proportionately decreased in the case of a combination. 
  
 6.4. Adjustment for Dividends in Stock or Other Securities or
Property. If, while this Warrant or any portion hereof remains outstanding and unexpired, the holders of the securities as to which purchase rights under this Warrant exist at the time shall have received, or, on or after the record date fixed
for the determination of eligible shareholders, shall have become entitled to receive, without payment therefor, other or additional stock or other securities or property (other than cash) of the Company by way of dividend, then, and in each case,
this Warrant shall represent the right to acquire, in addition to the number of shares of the security receivable upon exercise of this Warrant, and without payment of any additional consideration therefor, the amount of such other or additional
stock or other security or property (other than cash) of the Company that such holder would hold on the date of such exercise had it been the holder of record of the security receivable upon exercise of this Warrant on the date hereof and 

  

 - 5 - 

 
had thereafter, during the period from the date hereof to and including the date of such exercise, retained such shares and/or all other additional stock
available by it as aforesaid during such period, giving effect to all adjustments called for during such period by the provisions of this Section 6. 
  
 6.5. Certificate as to Adjustments. Upon the occurrence of each adjustment pursuant to this Section 6, the Company at its expense shall promptly
compute such adjustment in accordance with the terms hereof and furnish to the Holder a certificate setting forth such adjustment and showing in detail the facts upon which such adjustment is based, and the Exercise Price before and after the
adjustment. The Company shall, at any time upon the written request of any Holder, furnish to such Holder a certificate setting forth: (a) such adjustments; and (b) the Exercise Price then in effect; and (c) the number of shares and the amount, if
any, of other property that at the time would be received upon the exercise of the warrant. 
  
 6.6. No Impairment. The Company will not, by any voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at all
times in good faith assist in the carrying out of all the provisions of this Section 6 and in the taking of all such actions as may be necessary or appropriate in order to protect the rights of the Holder of this Warrant against impairment.

  
 7. Registration Rights. The Holder shall be able to
participate in any Initial Public Offering of the Company upon the same terms and conditions as management of the Company. If the Company proposes to register any its securities under the Securities Act of 1933, as amended, for sale to the public,
whether for its own account or for the account of other security holders or both, the Company at each such time will give written notice to the Holder of its intention to do so. Upon the written request of the Holder, given within 20 days after the
date of any such notice, to register any of its securities held hereunder (which request shall state the intended method of disposition thereof), the Company will use its best efforts to cause the securities as to which registration shall have been
so requested to be included in the securities to be covered by such registration statement proposed to be filed by the Company, subject to any limitations or restrictions placed on the securities owned by the management of the Company under the
terms of the Initial Public Offering. If requested, the Company shall provide for the benefit of the Holder and others claiming through the Holder, an agreement or agreements containing representations, warranties, indemnities, and other agreements
then customarily included by an issuer in underwriting agreements with respect to initial and secondary underwritten distributions, and in connection therewith, if an underwriting agreement is entered into, cause the same to contain customary
indemnification provisions and procedures and such other provisions and procedures reasonably acceptable to, and for the benefit of, the underwriters. For purposes of this Section 7, “Initial Public Offering” shall mean the sale by either
the Company or any of its subsidiaries of its capital stock pursuant to a registration statement on Form S-1 or otherwise under the Securities Act. 
  
 8. Amendments. This Warrant may not be amended without the prior written consent of the Holder. 
  

 - 6 - 

 9. Notices. Any notice, certificate or other communication which is required or convenient under
the terms of this Warrant shall be duly given if it is in writing and delivered in person or mailed by first class mail, postage prepaid, and directed to the Holder of the Warrant at its address as it appears on the Register, or, if to the Company,
to its principal executive offices. The time when such notice is sent shall be the time of the giving of the notice. 
  
 10. Time. Where this Warrant provides for a payment or performance on a Saturday or Sunday or a public holiday in the Commonwealth of Kentucky,
such performance may be made on the next succeeding business day. 
  
 11. Rules of Construction. In this Warrant, unless the context otherwise requires, words in the singular number include the plural, and in the plural include the singular, and words of the masculine gender include the feminine and
the neuter, and when the sense so indicates, words of the neuter gender may refer to any gender. The numbers and titles of sections contained in this Warrant are inserted for convenience of reference only, and they neither form a part of this
Warrant nor are they to be used in the construction or interpretation hereof. 
  
 12. Governing Law. The validity, terms, performance and enforcement of this Warrant shall be governed by those laws of the State of Delaware that are applicable to agreements that are negotiated, executed,
delivered and performed solely in the State of Delaware. 
  
 IN
WITNESS WHEREOF, HEALTHESSENTIALS SOLUTIONS, INC. has caused this Warrant to be executed by its officer thereto duly authorized. 
  

			
	 HEALTHESSENTIALS SOLUTIONS, INC.

		
	 BY:
	 	 /s/ Michael R. Barr

		
	 TITLE:
	 	 CEO

  

 - 7 -Regristration Rights Agreement

 Exhibit 10.31 
  
 REGISTRATION RIGHTS AGREEMENT 
  
 This REGISTRATION RIGHTS AGREEMENT is dated as of August 24, 1999, between HEALTHESSENTIALS SOLUTIONS, INC., a Delaware corporation (the
“Company”), and the persons listed on Exhibit A attached hereto and incorporated herein by reference (each a “Holder” and collectively, the “Holders”). 
  
 W I T N E S S E T H: 
  
 WHEREAS, the persons listed on Exhibit A attached hereto may become
the holders of up to 3,000,000 shares of the Common Stock of the Company, par value $.001, and have entered into a Securities Purchase Agreement dated as of August 24, 1999, with the Company pursuant to which the Company has agreed to issue up to an
aggregate of 3,000,000 shares of its common stock, par value $.001, to the Holders. 
  
 NOW, THEREFORE, in consideration of the premises and mutual covenants and agreements set forth herein and in the Securities Purchase Agreement, and for other good and valuable consideration, the mutuality, receipt and
sufficiency of which are hereby acknowledged, the parties hereto do hereby agree as follows: 
  
 1. Definitions. As used herein, unless the context otherwise requires, the following terms have the following respective meanings: 
  
 Commission: The Securities and Exchange Commission or any other Federal agency at the time administering the
Securities Act. 
  
 Common Shares: The Common Stock of the
Company, par value $.001 per share. 
  
 Company:
HealthEssentials Solutions, Inc., a Delaware corporation, and its successors and assigns. 
  
 Exchange Act: The Securities Exchange Act of 1934, or any similar Federal statute, and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time. 
  
 Holder: A Holder and any holder of Registrable Securities to whom the
registration rights conferred by this Agreement have been transferred in compliance with section 8 hereof. 
  
 Initial Public Offering: The first registration of equity securities of the Company under the Securities Act which becomes effective and pursuant
to which equity securities are sold. 
  
 Initiating Holder:
Any Holder or Holders (i) who hold not less than the greater of twenty percent (20%) or 500,000 shares of the Registrable Securities for purposes of registration pursuant to section 2.1 and (ii) who hold not less than the greater of ten percent
(10%) or 300,000 shares of the Registrable Securities for purposes of registration pursuant to section 2.3. 
  
 Person: An individual, a partnership, a limited liability company, a joint venture, a 

  

 
corporation, a trust, an unincorporated organization and a government or any department or agency thereof. 
  
 Registrable Securities: The Common Shares held by the Holders which
were originally issued to or are derived from any such shares originally issued to the Holders. As to any particular Registrable Securities, once issued such securities shall cease to be Registrable Securities when (i) a registration statement with
respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been disposed of in accordance with such registration statement, (ii) they shall have been sold pursuant to Rule 144 (or any
successor provision) under the Securities Act, (iii) they shall have been otherwise transferred and subsequent disposition of them shall not require registration or qualification of them under the Securities Act of or any similar state law then in
force, (iv) they shall have ceased to be outstanding, or (v) such Securities shall be eligible for sale pursuant to Rule 144(k). 
  
 Registration Expenses: All expenses incident to the Company’s performance of or compliance with section 2, including, without limitation, (i)
all registration, filing and NASD fees, (ii) all fees and expenses of complying with securities or blue sky laws, (iii) all word processing, duplicating and printing expenses, (iv) messenger and delivery expenses, (v) the fees and disbursements of
counsel for the Company and of its independent public accountants, including the expenses of any special audits or “cold comfort” letters required by or incident to such performance and compliance, and (vi) any fees and disbursements of
underwriters customarily paid by issuers or sellers of securities, but excluding underwriting discounts and commissions and transfer taxes, if any. 
  
 2. Registration under Securities Act. 
  
 2.1. Registration on Request. 
  
 (a) Request of Initiating Holder. At any time after an Initial Public Offering, upon the written request of an Initiating Holder
requesting that the Company effect the registration under the Securities Act of a specified number of the Registrable Securities, and specifying the intended method of disposition thereof, the Company will 
  
 (i) promptly give written notice of the proposed
registration to all other Holders, and 
  
 (ii)
use its best efforts to effect the registration under the Securities Act of the Registrable Securities which the Company has been so requested to register by the Initiating Holder and the Holders joining in such request in writing received by the
Company within 30 days after written notice from the Company of such registration (together with the Initiating Holder, the “Participating Holders”), 
  

for disposition in accordance with the intended method or methods of disposition stated in such request, to the extent requisite to permit the
disposition (in accordance with the intended methods thereof as aforesaid) of the Registrable Securities so to be registered, provided that (i) the Company shall not be required to effect any registration pursuant to this section 2.1(a) after two
registrations requested pursuant to this section 2.1(a) shall have been effected; (ii) the Company shall not be required to effect any registration pursuant to this section 2.1(a) during the period 

  

 2 

 
starting with the thirtieth day immediately preceding the date of anticipated filing by the Company of, and ending on a date 90 days following, the effective
date of the Company’s Initial Public Offering, provided that the Company is actively employing in good faith all reasonable efforts to cause such registration statement to become effective and that the Company’s estimate of the date of
filing such registration statement is made in good faith and, provided further, that such period shall end on such earlier date as may be permitted by the underwriters of such underwritten public offering; (iii) the Registrable Securities to be
registered (A) represent at least 20% of the Registrable Securities outstanding or (B) will result in an aggregate offering price of $5,000,000; and (iv) if the Company shall at any time furnish to the Initiating Holder a certificate (the
“Certificate”) signed by the President of the Company, stating that in his good faith opinion that it would be detrimental to the Company for such registration statement to be filed in the near future and that it is, therefore, essential
to defer the filing of such registration statement, then the Company shall have the right to defer such filing for the period during which such filing would be detrimental, provided that the Company shall not defer its obligation in this manner more
than twice in any twelve-month period. 
  
 (b)
Effective Registration Statement. A registration requested pursuant to this section 2.1 shall not be deemed to be effected (i) if a registration statement with respect thereto shall not have become effective, or (ii) if, after it has become
effective, such registration is interfered with for any reason by any stop order, injunction or other order or requirement of the Commission or any other governmental agency or any court (other than due to the act or omission of the Initiating
Holder), or (iii) if the conditions to closing specified in the purchase agreement or underwriting agreement entered into in connection with such registration shall not be satisfied or waived with the consent of the Initiating Holder, other than by
reason of some other act or omission by the Initiating Holder, or (iv) if an underwritten offering, the requested shares have not been sold to the underwriters. 
  
 (c) Registration Statement Form. Registrations under this section 2.1 shall be on such appropriate
registration form of the Commission as shall be selected by the Company and as shall permit the disposition of the Registrable Securities so to be registered in accordance with the intended method or methods of disposition specified in the request
of the Initiating Holder for such registration. The Company agrees to include in any such registration statement all information which the Initiating Holder shall reasonably request. 
  
 (d) Expenses. The Company will pay the Registration Expenses in connection with any registration
requested pursuant to this section 2.1. 
  
 (e)
Selection of Underwriters. If a requested registration pursuant to this section 2.1 involves an underwritten offering, the underwriter or underwriters shall be selected by the Company but only with the approval of the Initiating Holder, which
approval shall not be unreasonably withheld. 
  
 (f) Priority in Requested Registrations. If a requested registration pursuant to this section 2.1 involves an underwritten offering, and the managing underwriter shall advise the Company in writing (with a copy to the Initiating
Holder) that, in its opinion, the number of securities requested and otherwise proposed to be included in such registration exceeds the number which can be sold in such offering within a price range acceptable to the 

  

 3 

 
Initiating Holder, the Company will include in such registration to the extent of the number which the Company is so advised can be sold in such offering in
the case of any registration requested pursuant to section 2.1(a), first, the Registrable Securities requested to be included in such registration by the Initiating Holder and the Participating Holders, pro rata among such Holders on the basis of
the number of securities requested to be included by such Holders, and second, securities of the Company proposed by the Company to be sold for its own account. 
  
 (g) No Company Initiated Registration. After receipt of notice of a requested registration pursuant
to Section 2.1(a), the Company shall not initiate a registration of any of its securities for its own account until such time as the registration requested under Section 2.1(a) has been effected or has otherwise been terminated. Nothing herein,
however shall prohibit the Company from participating in such requested registration. 
  
 (h) No Grant of Future Demand Rights. For so long as there are at least 500,000 Registrable Securities outstanding, the Company
shall not grant demand registration rights to any other Person without the consent of Holders holding at least fifty-one percent (51 %) of the Registrable Securities. 
  
 2.2. Incidental Registration. 
  
 (a) Right to Include Registrable Securities. If the Company at any time proposes to register any of
its securities under the Securities Act (other than by a registration on Form S-4 or S-8 or any successor or similar forms or filed in connection with an exchange offer or any offering of securities solely to the Company’s existing
shareholders, and other than pursuant to section 2.1) on a form that would permit (or, without disrupting the transaction which the Company proposes to effect, could be changed to another form that would permit) the registration of the Registrable
Securities, whether or not for sale for its own account, the Company will each such time give prompt written notice to the Holders of its intention to do so and of the Holder’s rights under this section 2.2. Upon the written request of the
Participating Holders made within 30 days after the receipt of any such notice (which request shall specify the Registrable Securities intended to be disposed of by the Participating Holders and the intended method of disposition thereof), the
Company will use its best efforts to effect the registration under the Securities Act of all Registrable Securities which the Company has been so requested to register by the Participating Holders, to. the extent requisite to permit the disposition
(in accordance with the intended methods thereof as aforesaid) of the Registrable Securities so to be registered, provided that if, at any time after giving written notice of its intention to register any securities and prior to the effective date
of the registration statement filed in connection with such registration, the Company shall determine for any reason not to register or to delay registration of such securities, the Company may, at its election, give written notice of such
determination to the Participating Holders, and thereupon, (1) in the case of a determination not to register, shall be relieved of its obligation to register any Registrable Securities in connection with such registration (but not from its
obligation, if any, to pay the Registration Expenses in connection therewith), without prejudice, however, to the rights of the Participating Holders to request that such registration be effected as a registration under section 2.1, and (2) in the
case of a good faith determination to delay registering shall be permitted to delay registering any Registrable Securities, for the same period as the delay in registering such other securities but in no event shall such delay continue for more than
90 days, after which time the registration shall 

  

 4 

 
be deemed to be terminated. No registration effected under this section 2.2 shall relieve the Company of its obligation to effect any registration upon
request under section 2.1 except as and to the extent provided in clause (ii) of the proviso to section 2.1(a). 
  
 (b) Expenses. The Company will pay all Registration Expenses in connection with each registration of Registrable Securities
requested pursuant to this section 2.2. 
  
 (c)
Priority in Incidental Registrations. If a registration pursuant to this section 2.2 involves an underwritten offering, and the managing underwriter shall advise the Company in writing (with a copy to the Participating Holders), that, in its
opinion, the number of securities requested and otherwise proposed to be included in such registration exceeds the number which can be sold in such offering within a price range acceptable to the Company, the Company will include in such
registration, to the extent of the number which the Company is so advised can be sold in such offering if the registration is a primary registration on behalf of the Company, first, securities of the Company proposed by the Company to be sold for
its own account, second, Registrable Securities of the Participating Holders, pro rata among such Participating Holders on the basis of the number of Registrable Securities and other securities requested to be included by such Participating Holders.

  
 (d) Selection of Underwriters. If a
registration pursuant to this section 2.2 involves an underwritten offering, the underwriter or underwriters thereof shall be selected by the Company. 
  
 2.3. Registration on Form S-3. If at any time (i) an Initiating Holder requests in writing that the Company file under the
Securities Act a registration statement on Form S-3 (or any successor registration form to Form S-3 regardless of its designation) for a public offering of Registrable Securities; and (ii) the Company is a registrant entitled to use Form S-3 to
register such shares, then the Company shall use its best efforts to cause such shares to be registered on Form S-3 (or any successor registration form to Form S-3). The provisions of section 2.1(d) shall apply to the expenses of any registration
under this section 2.3. The Company shall not be required to honor any such request made within three months of the effective date of the registration of any of its securities (other than on Form S-4 or Form S-8) or any registration statement
pursuant to this section 2.3. The provisions of section 2.1(a)(C) allowing the Company to delay the registration shall apply to any request to file a registration statement under this section 2.3. 
  
 2.4. Registration Procedures. If and whenever the
Company is required to use its best efforts to effect the registration of any Registrable Securities under the Securities Act as provided in sections 2.1 and 2.2, the Company will as expeditiously as reasonably possible: 
  
 (i) prepare and (within 60 days after the end of the period
within which requests for registration may be given to the Company) file with the Commission the requisite registration statement to effect such registration and thereafter use its best efforts to cause such registration statement to become
effective; 
  

 5 

 (ii) prepare and file with the Commission such amendments and supplements to such
registration statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective for a period of either (A) not less than 90 days (subject to extension pursuant to the last paragraph of this
section 2.4) or, if such registration statement relates to an underwritten offering, such longer period as in the opinion of counsel for the underwriters a prospectus is required by law to be delivered in connection with sales of Registrable
Securities by an underwriter or dealer or (B) such shorter period as will terminate when all of the securities covered by such registration statement have been disposed of in accordance with the intended methods of disposition by the seller or
sellers thereof set forth in such registration statement (but in any event not before the expiration of any longer period required under the Securities Act), and to comply with the provisions of the Securities Act with respect to the disposition of
all securities covered by such registration statement until such time as all of such securities have been disposed of in accordance with the intended methods of disposition by the seller or sellers thereof set forth in such registration statement;

  
 (iii) furnish to the Participating Holders
such number of conformed copies of such registration statement and of each such amendment and supplement thereto (in each case including all exhibits), such number of copies of the prospectus contained in such registration statement (including each
preliminary prospectus and any summary prospectus) and any other prospectus filed under Rule 424 under the Securities Act, in conformity with the requirements of the Securities Act, and such other documents in order to facilitate the disposition of
the Registrable Securities owned by the Participating Holders, as the Participating Holders may reasonably request; 
  
 (iv) use its reasonable best efforts to register or qualify such Registrable Securities and other securities covered by such registration
statement under such other securities or blue sky laws of such jurisdiction as, in the case of any underwritten offering of Registrable Securities pursuant to a registration requested under Section 2.1, the Initiating Holder shall reasonably
request, or, in the case of any other registration, as the Participating Holders shall reasonably request, to keep such registration or qualification in effect for so long as such registration statement remains in effect, and take any other action
which may be reasonably necessary or advisable to enable the Participating Holders to consummate the disposition in such jurisdictions of the securities owned by the Participating Holders; provided that the Company shall not for any such purpose be
required to (A) qualify generally to do business as a foreign corporation in any jurisdiction where it would not otherwise be required to qualify but for the requirements of this subdivision (iv), (B) consent to general service of process in any
such jurisdiction, (C) subject itself to taxation in such jurisdiction, or (D) qualify such securities in any jurisdiction in which the blue sky authority requires that the Participating Holders submit any shares of Registrable Securities to the
terms, provisions and restrictions of any escrow, lock-up or similar agreement(s) for consent to sell Registrable Securities in such jurisdiction unless the Participating Holders agree to do so; 
  
 (v) use its reasonable best efforts to cause all Registrable
Securities covered by such registration statement to be registered with or approved by such other governmental agencies or authorities as may be necessary by virtue of the business and 

  

 6 

 
operations of the Company to enable the Participating Holders to consummate the disposition of such Registrable Securities; 
  
 (vi) furnish to the Participating Holders a signed
counterpart, addressed to the Participating Holders (and the underwriters, if any) of (A) an opinion of counsel for the Company, dated the effective date of such registration statement (and, if such registration includes an underwritten public
offering, dated the date of the closing under the underwriting agreement), reasonably satisfactory in form and substance to the Participating Holders, and (B) a “comfort” letter (unless the registration is pursuant to section 2.2 and such
a letter is not otherwise being furnished to the Company or the Participating Holders pursuant to section 2.2), dated the effective date of such registration statement (and, if such registration includes an underwritten public offering, dated the
date of the closing under the underwriting agreement), signed by the independent public accountants who have certified the Company’s financial statements included in such registration statement, covering substantially the same matters with
respect to such registration statement (and the prospectus included therein) and, in the case of the accountants’ letter, with respect to events subsequent to the date of such financial statements, as are customarily covered in opinions of
issuer’s counsel and in accountants’ letter delivered to the underwriters in underwritten public offerings of securities and, in the case of the accountants’ letter, such other financial matters, and, in the case of the legal opinion,
such other legal matters, as the Participating Holders (or the underwriters, if any) may reasonably request; 
  
 (vii) notify the Participating Holders at any time when a prospectus relating thereto is required to be delivered under the Securities
Act, upon discovery that, or upon the discovery of the happening of any event as a result of which, the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state any
material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances under which they were made, and at the request of the Participating Holders promptly prepare and furnish to the
Participating Holders a reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such securities, such prospectus shall not include an untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances under which they were made; 
  
 (viii) otherwise use its reasonable best efforts to comply
with all applicable rules and regulations of the Commission, and make available to its security holders, as soon as reasonably practicable, an earnings statement covering a period of twelve months, beginning with a calendar month commencing not more
than three months after the effective date of such registration statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act, and will furnish to the Participating Holders at least two business days prior
to the filing thereof a copy of any amendment or supplement to such registration statement or prospectus and shall not file any such amendment or supplement to which the Participating Holders shall have reasonably objected in writing on the grounds
that such amendment or supplement does 

  

 7 

 
not comply (explaining why) in all material respects with the requirements of the Securities Act or of the rules or regulations thereunder; 
  
 (ix) provide and cause to be maintained a transfer agent and
registrar for all Registrable Securities covered by such registration statement from and after a date not later than the effective date of such registration statement; and 
  
 (x) use its reasonable best efforts (A) to cause all such Registrable Securities covered by such
registration statement to be listed on a national securities exchange (if such Registrable Securities are not already so listed) and on each other securities exchange on which similar securities issued by the Company are then listed, if the listing
of such Registrable Securities is then permitted under the rules of such exchange; or (B) to secure the designation of all such Registrable Securities covered by such registration statement as a NASDAQ “national market system security”
within the meaning of Rule 11Aa2-1 of the Commission or, failing that, to secure NASDAQ authorization for such Registrable Securities and, without limiting the generality of the foregoing, to arrange for at least two market makers to register as
such with respect to such Registrable Securities with the National Association of Securities Dealers. 
  
 It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Agreement that each Holder shall furnish to the
Company such information regarding it, the ownership of the Registrable Securities held by it, and its intended method of disposition of such securities as the Company shall reasonably request and as shall be required by law in connection with the
action to be taken by the Company. 
  
 Upon receipt of any notice
from the Company of the happening of any event of the kind described in subdivision (vii) of this section 2.4, the Participating Holders will forthwith discontinue their disposition of Registrable Securities pursuant to the registration statement
relating to such Registrable Securities until receipt of the copies of the supplemented or amended prospectus contemplated by subdivision (vii) of this section 2.4 and, if so directed by the Company, the Participating Holders will use their best
efforts to deliver to the Company (at the Company’s expense) all copies, other than permanent file copies then in their possession, of the prospectus relating to such Registrable Securities current at the time of receipt of such notice. In the
event the Company shall give any such notice, the applicable time period mentioned in clause (ii) of this section 2.4 during which a Registration Statement is to remain effective shall be extended by the number of days during the period from and
including the date of the giving of such notice pursuant to this paragraph to and including the date when the Participating Holders shall have received the copies of the supplemented or amended prospectus contemplated by clause (vii) of this section
2.4. 
  
 2.5. Underwritten Offerings.

  
 (a) Requested Underwritten Offerings.
If an Initiating Holder designates an underwritten public offering as the intended method of disposition of Registrable Securities pursuant to a registration requested under section 2.1, the Company and the Participating Holders shall enter into an
underwriting agreement with the underwriter satisfactory in substance and form to the Initiating Holder which shall contain such 

  

 8 

 
representations and warranties by the Company and such other terms as are generally prevailing in agreements of this type, including, without limitation,
indemnities to the effect and to the extent provided in section 2.5. No underwriting agreement (or other agreement in connection with such offering) shall require a Participating Holder to make any representations or warranties to or agreements with
the Company or the underwriters other than representations, warranties or agreements regarding the Participating Holder, the ownership of the Participating Holder’s Registrable Securities, information provided in writing by the Participating
Holder for inclusion in a registration statement, and the Participating Holder’s intended method of distribution and any other representation required by law or reasonably required by the underwriters and acceptable to the Participating Holder.

  
 (b) Incidental Underwritten Offerings.
If the Company at any time proposes to register any of its securities under the Securities Act as contemplated by section 2.2 and such securities are to be distributed by or through one or more underwriters, the Company will, if requested by the
Participating Holders as provided in section 2.2 and subject to the provisions of section 2.2(b), use its best efforts to arrange for such underwriters to include all the Registrable Securities to be offered and sold by the Participating Holders
among the securities to be distributed by such underwriters. The Company shall not be required under section 2.2 to include any of a Participating Holder’s Registrable Securities in such underwriting unless such Participating Holders accept the
terms of the underwriting as have been reasonably agreed upon between the Company and the underwriters selected by it. Each Participating Holder shall be a party to the underwriting agreement between the Company and such underwriters and may, at its
option, require that any or all of the representations and warranties by, and the other agreements on the part of, the Company to and for the benefit of such underwriters shall also be made to and for the benefit of the Participating Holders. The
Company shall use its reasonable best efforts to assure that no underwriting agreement (or other agreement in connection with such offering) shall require a Participating Holder to make any representations or warranties to or agreements with the
Company or the underwriters other than representations, warranties or agreements regarding the Participating Holder, the ownership of the Participating Holder’s Registrable Securities, information provided in writing by the Participating Holder
for inclusion in a registration statement, and the Participating Holder’s intended method of distribution and any other representation required by law. 
  
 (c) Holdback Agreements. 
  
 (i) To the extent not inconsistent with applicable law, each Holder agrees by acquisition of such Registrable Securities not to effect
any public sale or distribution of any equity securities of the Company, or any securities convertible into or exchangeable or exercisable for such securities, including a sale pursuant to Rule 144 under the Securities Act (or any similar provision
then in force), during the seven days before and the 90 days after any underwritten registration has become effective, except as part of such underwritten registration. 
  
 (ii) The Company agrees (x) not to effect any public sale or distribution of its equity securities or
securities convertible into or exchangeable or exercisable for any of such securities during the seven days before and the 90 days (unless advised in writing by the managing underwriter that a longer period is required) 

  

 9 

 
after any underwritten registration pursuant to section 2.1 has become effective, except as part of such underwritten registration and except pursuant to
registrations on Form S-4 or S-8, or any successor or similar forms thereto, and (y) to cause each holder of its equity securities or any securities convertible into or exchangeable or exercisable for any of such securities, whether outstanding on
the date of this Agreement or issued at any time after the date of this Agreement (other than any such securities acquired in a public offering), to agree not to effect any such public sale or distribution of such securities during such period,
except as part of any such registration if permitted, provided that the provisions of this paragraph (ii) shall not prevent the conversion or exchange of any securities pursuant to their terms into or for other securities. 
  
 2.6. Indemnification. 
  
 (a) Indemnification by the Company. In the event of
any registration of any securities of the Company under the Securities Act, the Company will, and hereby does, indemnify and hold harmless in the case of any registration statement filed pursuant to section 2.1 or 2.2, each Participating Holder, its
directors and officers, each other Person who participates as an underwriter in the offering or sale of such securities and each other Person, if any, who controls a Participating Holder or any such underwriter within the meaning of the Securities
Act, against any losses, claims, damages or liabilities, joint or several, to which a Participating Holder or any such director or officer or controlling Person may become subject under the Securities Act or otherwise, insofar as such losses,
claims, damages or liabilities (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon (x) any untrue statement or alleged untrue statement of any material fact contained (A) in any
registration statement under which such securities were registered under the Securities Act, any preliminary prospectus, final prospectus or summary prospectus contained therein or used in connection with the offering of securities covered thereby,
or any amendment or supplement thereto, or (B) in any application or other document or communication (in this section 2.6 collectively called an “application”) executed by or on behalf of the Company or based upon written information
furnished by or on behalf of the Company filed in any jurisdiction in order to qualify any securities covered by such registration statement under the “blue sky” or securities laws thereof, or (y) any omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and the Company will reimburse each Participating Holder and each such director, officer, underwriter and controlling person for any
legal or any other expenses incurred by them in connection with investigating or defending any such loss, claim, liability, action or proceeding; provided that the Company shall not be liable to a Participating Holder in any such case to the extent
that any such loss, claim, damage, liability (or action or proceeding whether commenced or threatened in respect thereof) or expenses arises out of or is based upon an untrue statement or alleged untrue statement, or omission or alleged omission,
made in such registration statement, any such preliminary prospectus, final prospectus, summary prospectus, amendment or supplement, or in any application, in reliance upon and in conformity with written information prepared and furnished to the
Company by such Participating Holder specifically for use in the preparation thereof which information contained any untrue statement of any material fact or omitted to state therein a material fact required to be stated therein or necessary to make
the statements therein not misleading; provided, further, that the Company shall not be liable to a Participating Holder in any such case to the extent that any such loss, claim, damage, liability or 

  

 10 

 
expense is claimed by, for the benefit of, was incurred by or relates to any Person to which such Participating Holder sold such Registrable Securities to
and arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in any preliminary prospectus if (i) such Participating Holder was provided pursuant to section 2.4 (iii) with copies of the
final prospectus prior to the written confirmation of the sale of such Registrable Securities and failed to send or deliver a copy of the final prospectus with or prior to the delivery of written confirmation of the sale of such Registrable
Securities, and the prospectus would have completely corrected such untrue statement or omission; and provided, further, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage, liability or expense
arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission in the prospectus, if (x) such untrue statement or alleged untrue statement, omission or alleged omission is completely corrected in an
amendment or supplement to the prospectus, (y) having previously been furnished by or on behalf of the Company with copies of the prospectus as so amended or supplemented, a Participating Holder thereafter fails to deliver such prospectus as so
amended or supplemented prior to or concurrently with the sale of the Registrable Securities to the Person asserting such loss, claim, damage, liability or expenses who purchased such Registrable Securities which is the subject thereof from such
Participating Holder and (z) such loss, claim, damage, liability or expense would not have arisen if such Participating Holder had not so failed to deliver such prospectus as so amended or supplemented prior to or concurrently with such sale. Such
indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of a Participating Holder or any such director, officer, underwriter or controlling Person and shall survive the transfer of such securities by a
Holder. The indemnity agreement contained in this section 2.6(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, or option if such settlement is effected without the consent of the Company (which consent
shall not be unreasonably withheld). 
  
 (b)
Indemnification by Holders. Each Participating Holder, for the sale of Registrable Securities included in any registration statement filed pursuant to section 2.1 or 2.2, will indemnify and hold harmless (in the same manner and to the same
extent as set forth in subdivision (a) of this section 2.6) the Company, each director of the Company, each officer of the Company who signs the registration statement and each other Person, if any, who controls the Company within the meaning of the
Securities Act, with respect to any statement or alleged statement in or omission or alleged omission from such registration statement, any preliminary prospectus, final prospectus or summary prospectus contained therein, or any amendment or
supplement thereto, or any application, if such statement or alleged statement or omission or alleged omission was made in reliance upon and in conformity with written information prepared and furnished to the Company by such Participating Holder
specifically for use in the preparation of such registration statement, preliminary prospectus, final prospectus, summary prospectus, amendment or supplement, or such application, which information contained any untrue statement of any material fact
or omitted to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading. Such indemnity shall remain in full force and effect, regardless of any investigation made by or on behalf of the
Company or any such director, officer or controlling Person and shall survive the transfer of such securities by such Participating Holder. The indemnity agreement contained in this section 2.6(b) shall not apply to amounts paid in settlement of any
such loss, claim, damage, liability or action if such settlement is effected without the consent of such Participating Holder (which consent shall not 

  

 11 

 
be unreasonably withheld). The indemnity provided by each Participating Holder under this section 2.6(b) shall be provided severally and not jointly with any
other seller or prospective seller of securities and shall be limited in amount to the net amount of proceeds received by each Participating Holder from the sale of Registrable Securities pursuant to such registration statement. 
  
 (c) Notices of Claims etc. Promptly after receipt by
an indemnified party of notice of the commencement of any action or proceeding involving a claim referred to in the preceding subdivisions of this section 2.6, such indemnified party will, if a claim in respect thereof is to be made against an
indemnifying party, give written notice to the latter of the commencement of such action, provided that the failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its obligations except
to the extent that the indemnifying party is materially prejudiced by such failure to give notice. In case any such action is brought against an indemnified party, unless in such indemnified party’s reasonable judgment a conflict of interest
between such indemnified and indemnifying parties may exist in respect of such claim, the indemnifying party shall be entitled to participate in and to assume the defense thereof, jointly with any other indemnifying party similarly notified to the
extent that it may wish, with counsel reasonably satisfactory to the parties, and after notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, if the indemnifying party is entitled to do so
hereunder, the indemnifying party shall not be liable to such indemnified party for any legal or other expenses subsequently incurred by the latter in connection with the defense thereof other than reasonable costs of investigation. No indemnifying
party shall, without the consent of the indemnified party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a
release from all liability in respect to such claim or litigation. 
  
 (d) Indemnification Payments. The indemnification required by this section 2.6 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are
received or expense, loss, damage or liability is incurred. 
  
 (e) Contribution. To the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect to any amounts for which
it would otherwise be liable under this section 2.6 to the extent permitted by law; provided that no contribution shall be made under circumstances where the maker would not have been liable for indemnification under the fault standards set forth in
this section 2.6, and contribution by a Participating Holder shall be limited in amount to the net amount of proceeds received by a Participating Holder from the sale of such Registrable Securities. 
  
 2.7. Adjustments Affecting Registrable Securities.
The Company will not intentionally take any action with the purpose of effecting or permitting to occur any combination or subdivision of shares which would adversely affect the ability of the Holders to include Registrable Securities in any
registration of its securities contemplated by this section 2 or the marketability of Registrable Securities under any such registration. In connection with the Initial Public Offering, the Company will effect such subdivision of Common Shares as
may be 

  

 12 

 
reasonably recommended by the underwriters to increase the marketability of the Registrable Securities. 
  
 3. Rule 144. If the Company shall have filed a registration statement
pursuant to section 12 of the Exchange Act or a registration statement pursuant to the Securities Act, the Company will file the reports required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted
by the Commission thereunder and will take such further action as the Holders may reasonably request, all to the extent required from time to time to enable Holders to sell Registrable Securities without registration under the Securities Act within
the limitation of the exemptions provided by (a) Rule 144 under the Securities Act, as such Rule may be amended from time to time, or (b) any similar rule or regulation hereafter adopted by the Commission. Upon the request of a Holder, the Company
will deliver to a Holder a written statement as to whether it has complied with such requirements. 
  
 4. Amendments and Waivers. This Agreement may be amended and the Company may take any action herein prohibited, or omit to perform any act herein
required to be performed by it, if the Company shall have obtained the prior written consent to such amendment, action or omission to act of (i) if such amendment, action or omission to act adversely affects the interests of any of the Holders of
the Registrable Securities, the Holders of all the Registrable Securities whose interests are adversely affected at the time outstanding, and (ii) if such amendment, action or omission to act does not adversely affect the interests of the Holders of
any Registrable Securities, the Holders of at least 51% of Registrable Securities in the aggregate at the time outstanding, provided that without the written consent of all the Registrable Securities at the time outstanding, no such amendment
or waiver shall modify section 2.5. 
  
 5. Notices. All
communications provided for hereunder shall be in writing and shall be delivered personally or by telephone facsimile or telex or sent by first-class mail and (a) if to the Holders, addressed in the manner set forth in the Agreement for the Purchase
and Sale of Securities or at such other address as the Holders shall have furnished to the Company in writing, (b) if to the Company, addressed to it at 9721 Ormsby Station Road, Louisville, Kentucky 40223, Attention: President with a copy to
Corporate Counsel, and (c) if to any other Holder, addressed in the manner set forth in section 8. 
  
 6. Assignment. This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective
successors and assigns. In addition, and whether or not any express assignment shall have been made, the provisions of this Agreement which are for the benefit of the Holders as such shall be for the benefit of and enforceable by any subsequent
Holder of any Registrable Securities (or such portion thereof), subject to the provisions respecting the minimum numbers or percentages of shares of Registrable Securities (or of such portion thereof) required in order to be entitled to certain
rights, or take certain actions contained herein. 
  
 7.
Notification of Registration. The Company will give to each Holder (i) prompt written notice of the filing of any registration statement pursuant to the requirements of section 12 of the Exchange Act relating to equity securities of the
Company setting forth the number of shares of each class of equity securities of the Company outstanding at the time of such filing, 

  

 13 

 
and (ii) prompt written notice of the number of shares of each class or equity securities of the Company outstanding at the time such registration statement
becomes effective. 
  
 8. Transfer of Registration Rights.
The rights of a Holder under this Agreement with respect to any Registrable Securities may be transferred to any transferee of such Registrable Securities; provided, however, that the Company is given written notice by the Holder or the subsequent
transferor at or prior to the time of such transfer stating the name and address of the transferee and identifying the securities with respect to which the rights under this Agreement are being assigned; provided further, however, that such rights
shall be transferable only if and to the extent the Registrable Securities are transferable under applicable laws and regulations. 
  
 9. Nominees for Beneficial Owners. In the event that Registrable Securities are held by a nominee for a Holder, such Holder may, at its option and
by written notice to the Company, be treated as the Holder of such Registrable Securities for purposes of any request or other action by any Holder or Registrable Securities pursuant to this Agreement. 
  
 10. Descriptive Headings. The descriptive headings of the several
sections and paragraphs of this Agreement are inserted for reference only and shall not limit or otherwise affect the meaning hereof. 
  
 11. Governing Law. This Agreement shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws
of the State of Delaware. 
  
 12. Counterparts. This
Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original, but all such counterparts shall together constitute one and the same instrument. 
  
 13. Severability. In the event that any one or more of the provisions
contained herein, or the application thereof in any circumstances, is held invalid, illegal or unenforceable in any respect for any reason, the validity, legality and enforceability of any such provision in every other respect and of the remaining
provisions contained herein shall not be in any way impaired thereby, it being intended that all of the rights and privileges of the Holders shall be enforceable to the fullest extent permitted by law. 
  
 14. Entire Agreement. This Agreement is intended by the parties hereto
as a final expression of their agreement and intended to be a complete and exclusive statement of their agreement and understanding in respect to the subject matter contained herein. This Agreement supersedes all prior agreements and understandings
between the parties with respect to such subject matter. 
  

 14 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first written
above. 
  

			
	 HEALTHESSENTIALS SOLUTIONS, INC.,
 a Delaware corporation

		
	 By:
	 	 /s/ Michael R. Barr

	 	 	 Michael R. Barr,

	 	 	 President

	
	The Holders signatures appear on Exhibit A attached hereto and incorporated herein by reference

  

 15 

 EXHIBIT A 
  

	
	
	/s/ Nolen C. Allen
	 Nolen C. Allen

	
	/s/ William L. Hysinger
	 William L. Hysinger

	
	/s/ J. Robert Shaver
	 J. Robert Shaver

	
	/s/ Kathryn S. Graham
	 Kathryn S. Graham

	
	/s/ Frederic H. Davis
	 Frederic H. Davis

	
	/s/ Darryl T. Traylor
	 Darryl T. Traylor

	
	/s/ Keith M. Perry
	 Keith M. Perry

	
	/s/ Jerry Stafford
	 Jerry Stafford

	
	/s/ W. Bruce Lunsford
	 W. Bruce Lunsford

  

 16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]